Derived Summary Stage 2018: Urethra

Derived Summary Stage 2018

Default

9

NAACCR Item

NAACCR #762
SS2018 Description
0 In situ, intraepithelial, noninvasive Papillary - Non-infiltrating or non-invasive papillary transitional cell carcinoma - Non-infiltrating or non-invasive papillary urothelial carcinoma - Papillary transitional cell carcinoma, with inferred description of non-invasion - Papillary urothelial carcinoma, with inferred description of non-invasion Nonpapillary - Carcinoma in situ, NOS - Sessile (flat) (solid) carcinoma in situ - Transitional cell carcinoma in situ - Urothelial carcinoma (in situ, non-infiltrating, non-invasive) Multifocal non-invasive tumors Urethra-Prostatic Carcinoma in situ involving (WITHOUT stromal invasion) - Periurethral or prostatic ducts - Prostatic urethra
1 Localized only (localized, NOS) - Muscularis invaded - Subepithelial connective tissue (lamina propria, submucosa) invaded
2 Regional by direct extension only - All sites + Bladder neck - Urethra + Corpus cavernosum + Corpus spongiosum + Periurethral muscle (sphincter muscle) + Vagina (anterior, NOS) - Prostatic urethra + Periprostatic fat (beyond prostate capsule) + Prostate (prostatic stroma) + Prostatic ducts
3 Regional lymph node(s) involved only - Iliac (common, external, internal [hypogastric] [obturator], NOS) - Inguinal (superficial [femoral], NOS) - Inguinal, deep (Node of Cloquet or Rosenmuller [highest deep inguinal], NOS) - Pelvic, NOS (including true pelvis) - Perivesical - Presacral - Sacral, NOS - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + All sites * Adjacent organ(s), NOS * Bladder wall + Prostatic urethra * Rectal wall - Distant lymph node(s), NOS - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis